Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « concerns »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
concerning < concerns < concert  Facettes :

List of bibliographic references indexed by concerns

Number of relevant bibliographic references: 62.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000094 (2021) Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde]The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
000147 (2021) Anthony Touafchia [France] ; Haleh Bagheri [France] ; Didier Carrié [France] ; Geneviève Durrieu [France] ; Agnès Sommet [France] ; Laurent Chouchana [France] ; François Montastruc [France]Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns.
000223 (2021) Jessica M. Franklin [États-Unis] ; Kueiyu Joshua Lin [États-Unis] ; Nicolle M. Gatto [États-Unis] ; Jeremy A. Rassen [États-Unis] ; Robert J. Glynn [États-Unis] ; Sebastian Schneeweiss [États-Unis]Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19.
000260 (2021) Keisuke Kuroda [Japon] ; Cong Li [Japon] ; Kiran Dhangar [Inde] ; Manish Kumar [Inde]Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters.
000303 (2021) Jun Chen [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine]New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals.
000311 (2021) Aitebiremen Gift Omokhua-Uyi [Afrique du Sud] ; Johannes Van Staden [Afrique du Sud]Natural product remedies for COVID-19: A focus on safety.
000366 (2021) Emmaline Zantua Fernando [Philippines] ; Jeryl Ritzi Tan Yu [Philippines] ; Salvador Miclat Abad Santos [Philippines] ; Roland Dominic Go Jamora [Philippines]Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia.
000378 (2021) Melanie M. Taylor [États-Unis] ; Loulou Kobeissi [Suisse] ; Caron Kim [Suisse] ; Avni Amin [Suisse] ; Anna E. Thorson [Suisse] ; Nita B. Bellare [Suisse] ; Vanessa Brizuela [Suisse] ; Mercedes Bonet [Suisse] ; Edna Kara [Suisse] ; Soe Soe Thwin [Suisse] ; Hamsadvani Kuganantham [Suisse] ; Moazzam Ali [Suisse] ; Olufemi T. Oladapo [Suisse] ; Nathalie Broutet [Suisse]Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action.
000426 (2021) Lucie Pothen [Belgique] ; Halil Yildiz [Belgique] ; Mathilde Mbouck Samnick [Royaume-Uni] ; Jean Cyr Yombi [Belgique]Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
000445 (2021) Heba Hussein ; Ronald Brown [États-Unis]Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19.
000446 (2021) Massimo Nicol [Italie] ; Lorenzo Ferro Desideri [Italie] ; Matteo Bassetti [Italie] ; Carlo Enrico Traverso [Italie]Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.
000548 (2021) Andrea Giacomelli [Italie] ; Gabriele Pagani [Italie] ; Anna L. Ridolfo [Italie] ; Letizia Oreni [Italie] ; Federico Conti [Italie] ; Laura Pezzati [Italie] ; Lucia Bradanini [Italie] ; Giacomo Casalini [Italie] ; Cinzia Bassoli [Italie] ; Valentina Morena [Italie] ; Simone Passerini [Italie] ; Giuliano Rizzardini [Italie, Afrique du Sud] ; Chiara Cogliati [Italie] ; Elisa Ceriani [Italie] ; Riccardo Colombo [Italie] ; Stefano Rusconi [Italie] ; Cristina Gervasoni [Italie] ; Dario Cattaneo [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie]Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study.
000589 (2021) Matthew P. Fox ; Lucy D'Agostino Mcgowan ; Bryan D. James ; Justin Lessler ; Shruti H. Mehta ; Eleanor J. MurrayConcerns About the Special Article on Hydroxychloroquine and Azithromycin in High-Risk Outpatients With COVID-19.
000635 (2021) Edward J. Calabrese [États-Unis] ; Jaap C. Hanekamp [Pays-Bas] ; Yannic N. Hanekamp [Pays-Bas] ; Rachna Kapoor [États-Unis] ; Gaurav Dhawan [États-Unis] ; Evgenios Agathokleous [République populaire de Chine]Chloroquine commonly induces hormetic dose responses.
000690 (2021) Carlotta Sciaccaluga [Oman] ; Matteo Cameli [Italie] ; Daniele Menci [Italie] ; Giulia Elena Mandoli [Italie] ; Nicol Sisti [Italie] ; Paolo Cameli [Italie] ; Federico Franchi [Italie] ; Sergio Mondillo [Italie] ; Serafina Valente [Italie]COVID-19 and the burning issue of drug interaction: never forget the ECG.
000740 (2021) Viktorija Dragojevic Simic [Serbie] ; Milijana Miljkovic [Serbie] ; Dusica Stamenkovic [Serbie] ; Berislav Vekic [Serbie] ; Nenad Ratkovic [Serbie] ; Radoje Simic [Serbie] ; Nemanja Rancic [Serbie]An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine.
000758 (2021) Lorenzo A. Cal [Italie] ; Matteo Rigato [Italie] ; Luca Sgarabotto [Italie] ; Lisa Gianesello [Italie] ; Giovanni Bertoldi [Italie] ; Verdiana Ravarotto [Italie] ; Paul A. Davis [États-Unis]ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes.
000780 (2021) Tien-Tzu Tai [Taïwan] ; Tzung-Ju Wu [Taïwan] ; Huey-Dong Wu [Taïwan] ; Yi-Chen Tsai [Taïwan] ; Hui-Ting Wang [Taïwan] ; An-Min Wang [Taïwan] ; Sheue-Fang Shih [Taïwan] ; Yee-Chun Chen [Taïwan]A Strategy to Treat COVID-19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study.
000788 (2021) Chris R. Triggle [Qatar] ; Devendra Bansal [Qatar] ; Hong Ding [Qatar] ; Md Mazharul Islam [Qatar] ; Elmoubashar Abu Baker Abd Farag [Qatar] ; Hamad Abdel Hadi [Qatar] ; Ali A. Sultan [Qatar]A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic.
000922 (2020) Cristina Silvestri [Italie] ; Silvio Di Stante [Italie] ; Veronica Bertuzzi [Italie] ; Mauro Martello [Italie] ; Marco Palladino [Italie] ; Xhensila Grabocka [Italie] ; Hrissanthi Kulurianu [Italie] ; Flavia Manenti [Italie] ; Francesca Pizzolante [Italie] ; Assunta Cardillo [Italie] ; Angelo Francioso [Italie] ; Osmy Paci Della Costanza [Italie] ; Chiara Valentini [Italie] ; Marina Di Luca [Italie][SARS CoV-2 related disease features in a population of chronic hemodialysis patients].
000989 (2020) Gabriela Mariana Iancu ; Adelaida Solomon ; Victoria Birlutiu [Roumanie]Viral exanthema as manifestation of SARS-CoV-2 infection: A case report.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "concerns" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "concerns" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    concerns
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021